Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaglucin vs Imiquimod for Anogenital Warts
NCT03901690Phase 3Unknown
- Sponsor
- CIMEC
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of beta-glucans + saccharomyces cerevisiae in anogenital warts, sponsored by CIMEC. Status: unknown.
02
Drugs
beta-glucans + saccharomyces cerevisiae
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT03901690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901690.